Table 2 Meta-analysis of association between evaluated SNHG6 expression and four clinicopathological characteristics
Clinicopathological parameters | Studies (n) | Patients (n) | OR (95% CI) | p-value | Heterogeneity | ||
|---|---|---|---|---|---|---|---|
I2 | Ph | Model | |||||
Tumor invasion depth (T3–4 VS T1–2) | 4 | 309 | 1.76 (1.18–2.63) | 0.006 | 0.24 | 0.972 | fixed |
Lymph node metastasis (Yes vs No) | 8 | 610 | 1.60 (1.18–2.17) | 0.002 | 5.57 | 0.591 | fixed |
Distant metastasis (Yes vs No) | 8 | 590 | 1.90 (1.37–2.64) | < 0.001 | 0.73 | 0.998 | fixed |
TNM stage (III-IV vs I-II) | 6 | 484 | 1.88 (1.36–2.60) | < 0.001 | 1.3 | 0.935 | fixed |